Market Place
Sourcing Support
Apellis`s Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit
14 May 2024 //
PRESS RELEASE
Serb Pharmaceutical Acquires Rights to SFJ`s Bentracimab
11 May 2023 //
CONTRACT PHARMA
Bankrupt PhaseBio settles with investor-partner, handing off late-stage drug
18 Jan 2023 //
ENDPTS
SFJ Pharma Announces Closing of Transfer of Bentracimab Assets from PhaseBio
17 Jan 2023 //
BUSINESSWIRE
SFJ plays hardball, demands rights to PhaseBio`s lead candidate
28 Sep 2022 //
ENDPTS
PhaseBio and SFJ Announce Approval of IND Application in China for Bentracimab
10 Aug 2021 //
BUSINESSWIRE
Nektar Announces Collaboration with SFJ Pharmaceuticals® for Bempegaldesleukin
17 Feb 2021 //
PRESS RELEASE
SFJ Pharmaceuticals® partner, Apellis, enters Strategic Collaboration
27 Oct 2020 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.